产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 250mg | 95% | 现货 | |||
| 1g | 95% | 现货 | |||
| 5g | 95% | 现货 | |||
| 25g | 95% | 现货 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 250mg | 95% | 现货 | |||
| 1g | 95% | 现货 | |||
| 5g | 95% | 现货 | |||
| 25g | 95% | 现货 |
CAS No. |
124832-31-1 |
|---|---|
中文名称 |
(S)-2-((2-氨基-6-氧代-1H-嘌呤-9(6H)-基)甲氧基)乙基 2-(((苄氧基)羰基)氨基)-3-甲基丁酸酯 |
英文名称 |
(S)-2-((2-Amino-6-oxo-1H-purin-9(6H)-yl)methoxy)ethyl 2-(((benzyloxy)carbonyl)amino)-3-methylbutanoate |
别名 |
2-[(2-AMINO-6-OXO-1,6-DIHYDRO-9H-PURIN-9-YL)METHOXY]ETHYL N-(BENZYLOXYCARBONYL)-L-VALINATE;Cbz-Valaciclovir;Valacyclovir Related Compound E (25 mg) (2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-[(benzyloxy)carbonyl]-L-valinate);N-[(Phenylmethoxy)carbonyl]-L-valine 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]ethyl ester;CBZ VALACYCLOVIR;2-[(2-AMino-6-oxo-1,6-dihydro-9H-purin-9-yl)Methoxy]ethyl N-(benzyloxycarbonyl)-L-valinate;Valaciclovir impurity E (PhEur);Valaciclovir Related Compound E (USP) |
标准英文名 |
2-((2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy)ethyl ((benzyloxy)carbonyl)-L-valinate |
MDL No. |
MFCD08273968 |
分子式 |
C21H26N6O6 |
分子量 |
458.48 |
精确分子量 |
458.19 |
SMILES |
CC(C)[C@H](NC(OCC1=CC=CC=C1)=O)C(OCCOCN2C=NC3=C2N=C(N)NC3=O)=O |
标准SMILES |
CC(C)[C@H](NC(=O)OCC1=CC=CC=C1)C(=O)OCCOCN1C=NC2=C1N=C(N)NC2=O |
性状 |
Solid |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
ZQSUAJRZJTUOEA-HNNXBMFYSA-N |
危险类别(旧) |
H302,H312,H332 |
存储要求 |
Keep in dark place,Inert atmosphere,2-8°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral (Category 4),Acute toxicity, dermal (Category 4),Acute toxicity, inhalation (Category 4) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|